hydrochloride. The glucosamine hydrochloride in Avoca ASU is plant based, and therefore would have no risk of side effects in people with shellfish allergy.
On page 38, Table 3 , "Nutramax" has been misspelled as "Nuramax."
On page 39, Table 4 , we state "references 106, 129, 130." In fact, references are 106, 128, 130.
On page 37, we state, "Further prospective multicenter studies are warranted to investigate whether other microscopic colitis cases 129 are observed in patients treated with Piascledine." In fact, we conclude that further prospective multicenter studies are warranted to investigate microscopic colitis cases; however, this is not specific to the use of Piascledine.
On page 39, in the Declaration of Conflicting Interests, we state "Simrit Bhatti and Dr. Ramin Goudarzi are employees of Formulation Technology Inc. and Pharmin USA, LLC, respectively." In fact, Simrit Bhatti is an employee of Formulation Technology Inc.; however, Dr. Ramin Goudarzi is the Principal of Pharmin USA, LLC."
The changes in Table 3 , page 39, are as follows: Abbreviations: ASU = avocado/soybean unsaponifiable; BHT = butylated hydroxytoluene; CC = calcium carbonate; c = cellulose; CAS = colloidal anhydrous silica; DCP = dicalcium phosphate; HPC = hydroxypropyl cellulose; HPMC = hydroxypropyl methylcellulose; MS = magnesium stearate; Mg = magnesium; MSM = methylsulfonylmethane; MCC = microcrystalline cellulose; PEG = polyethylene glycol; SDO = silicon dioxide; Na = sodium; SPI = soy protein isolate; SA = stearic acid; TDO = titanium dioxide.
The authors acknowledge the above factual errors and misspellings.
